Difficulty: Medium
Average Score: 80%
Practice
A 42-year-old man with HIV disease is hospitalized for refractory fungemia. He has begun on a course of caspofungin. After administration of the first intravenous dose, the patient develops flushing and sweats. What is the most likely mechanism of action for this finding?
Correct answer
A
Rationale
The correct answer is A) Histamine release from mast cells. Caspofungin is an echinocandin antifungal agent that can cause histamine release leading to symptoms like flushing and sweats. Echinocandins inhibit the synthesis of beta-(1,3)-D-glucan in the fungal cell wall, which does not directly cause the symptoms but can trigger histamine release. This is known as a non-IgE-mediated histamine release, leading to the observed symptoms in the patient.
Option B) Pancreatic pseudocyst, Option C) Parathyroid adenoma, and Option D) Parathyroid hyperplasia are unrelated to the patient's symptoms in the context of caspofungin administration. Understanding drug mechanisms of action and potential side effects is crucial in pharmacology. In this case, linking caspofungin's mechanism to histamine release highlights the importance of recognizing adverse effects and their underlying mechanisms in clinical practice. This knowledge helps healthcare providers anticipate and manage potential complications, ensuring optimal patient care.
Option B) Pancreatic pseudocyst, Option C) Parathyroid adenoma, and Option D) Parathyroid hyperplasia are unrelated to the patient's symptoms in the context of caspofungin administration. Understanding drug mechanisms of action and potential side effects is crucial in pharmacology. In this case, linking caspofungin's mechanism to histamine release highlights the importance of recognizing adverse effects and their underlying mechanisms in clinical practice. This knowledge helps healthcare providers anticipate and manage potential complications, ensuring optimal patient care.